| Oct 14 |
With 77% institutional ownership, Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst the big guns
|
| Oct 11 |
Bristol Myers Squibb (BMY) Stock Falls Amid Market Uptick: What Investors Need to Know
|
| Oct 11 |
Top Research Reports for Bristol-Myers, Arthur J. Gallagher & TC Energy
|
| Oct 9 |
BMY Buoyed by Recent Regulatory Updates: How to Play the Stock?
|
| Oct 9 |
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?
|
| Oct 7 |
Exelixis Gains 20.7% in Three Months: Is This the Right Time to Buy?
|
| Oct 7 |
Pfizer Stock Slump: Will Starboard's Billion-Dollar Bet Spark Rebound?
|
| Oct 7 |
Old Drug Repurposed for Schizophrenia Could Reap Alzheimer’s Windfall
|
| Oct 6 |
Bristol Myers Squibb: A High-Yield Bargain With Growth On The Horizon
|
| Oct 5 |
Bristol-Myers Squibb Company (BMY): A Buzzing AI Health Stock to Add to Your Portfolio
|
